[1]
“India’s Use of Patent Opposition Mechanism as an Access to Drugs Strategy: An Empirical Analysis”, JIPR, vol. 29, no. 4, pp. 253–264, Jul. 2024, doi: 10.56042/jipr.v29i4.3704.